Advertisement
Advertisement
U.S. markets open in 6 hours 5 minutes
S&P Futures
3,986.00 +8.00 (+0.20%) Dow Futures
32,395.00 +76.00 (+0.24%) Nasdaq Futures
12,862.00 +8.00 (+0.06%) Russell 2000 Futures
1,742.30 +9.80 (+0.57%) Crude Oil
70.23 +0.27 (+0.39%) Gold
1,990.60 -5.30 (-0.27%)
Sonic Healthcare Limited (SKHHY)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
At close: 03:47PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 23.05 |
| Open | 23.03 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 22.76 - 23.07 |
| 52 Week Range | 18.52 - 28.00 |
| Volume | |
| Avg. Volume | 56,883 |
| Market Cap | 10.71B |
| Beta (5Y Monthly) | 0.52 |
| PE Ratio (TTM) | 15.95 |
| EPS (TTM) | 1.43 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.69 (3.00%) |
| Ex-Dividend Date | Mar 06, 2023 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for SKHHY
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- SONIC HEALTHCARE SPON ADR EACHAnalyst Report: MERCK Kommanditgesellschaft auf AktienMerck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (46% of 2021 sales) provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (36%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.RatingFair ValueEconomic Moat9 days agoMorningstar
- Simply Wall St.
Sonic Healthcare Limited (ASX:SHL) Looks Interesting, And It's About To Pay A Dividend
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Sonic...
- Simply Wall St.
Sonic Healthcare (ASX:SHL) Will Pay A Larger Dividend Than Last Year At A$0.42
Sonic Healthcare Limited ( ASX:SHL ) has announced that it will be increasing its periodic dividend on the 22nd of...
- Simply Wall St.
Sonic Healthcare First Half 2023 Earnings: Revenues Miss Expectations
Sonic Healthcare ( ASX:SHL ) First Half 2023 Results Key Financial Results Revenue: AU$4.08b (down 14% from 1H 2022...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
